# LOYON ## Facts | | | |---|---| | Founded | 2014 | | Origin | Germany | | Headquarters | Hohenlockstedt | | Owner | G. Pohl-Boskamp GmbH & Co. KG | | Status | Active | | Distribution | Pharmacy | | Website | https://www.loyon-schuppen.de/ | LOYON is a German brand of scale-removing skin products made by G. Pohl-Boskamp GmbH & Co. KG, a family-owned pharmaceutical manufacturer based in Hohenlockstedt in the state of Schleswig-Holstein [1]. Its core product is a keratolytic, meaning a preparation that loosens and removes the thickened scales and crusts that build up on the skin in conditions such as psoriasis, seborrhoeic eczema and infant scalp crusting. It is sold as a medical device rather than as a medicine or a cosmetic, and its maker says it works purely physically, without acting on the body's metabolism [2]. The range consists of two products: the LOYON solution itself, a silicone-oil preparation applied by pipette or spray head, and LOYON Care, a fat-free moisturising fluid for dry, scaly and itchy skin. Outside its maker's own channels, LOYON has been covered mainly in the German pharmacy trade press, most notably for a randomised study that compared it with salicylic acid in patients with scalp psoriasis [8]. The brand is active and is sold through pharmacies. Its maker styles the name in capitals as LOYON®, while trade journals often write it as Loyon. ## Ownership LOYON belongs to G. Pohl-Boskamp, which labels it on the brand website as "a product of Pohl Boskamp" [1]. The website's legal notice names G. Pohl-Boskamp GmbH & Co. KG as the responsible company. This is a German form of limited partnership, registered at the district court in Pinneberg, whose general partner is itself a limited company, Boskamp GmbH [5]. Pohl-Boskamp describes itself as a medium-sized family business now in its fourth generation, and as one of Germany's most successful independent pharmaceutical producers [1]. According to the company, it develops both medicines and digital health applications, and its branded products address complaints ranging from respiratory illness and cardiovascular problems to tinnitus. Its range includes the respiratory medicines GeloMyrtol forte and GeloBronchial and the valerian preparation Baldurat. On its corporate website, the company files LOYON among its "Haut & Haar" (skin and hair) brands [7]. No change of ownership has been documented for LOYON. ## Philosophy & positioning LOYON is built around a single idea: removing scales gently rather than by force. Its tagline, "LOYON löst. Schuppen. Konsequent. Schonend.", translates roughly as "LOYON loosens. Scales. Consistently. Gently." The homepage presents the product as a keratolytic with a "purely physical" principle of action, and the owner's LOYON page repeats the second half of the slogan as its heading. The brand spends some effort explaining why scale removal matters at all. In scaly skin diseases, it says, the skin's normal renewal is disturbed, so dead cells collect on the surface and come away poorly. According to LOYON, a heavy layer of scales both makes the skin look abnormal and weakens its protective function. It also makes it harder for creams, ointments and light therapy to reach the skin underneath. Once the scales are gone, the company says, the skin can recover more quickly, and follow-up anti-inflammatory treatment with ointments or UV light becomes more effective. LOYON is therefore framed as a preparatory step that supports other treatments, not as a cure for the underlying disease. The website sets out the biology in plain terms. Skin cells renew constantly, moving up from the lower layers of the skin until they are shed from the surface as dead, horny scales. In many scaly skin diseases this process goes wrong in the outermost layer, the epidermis, and scales and crusts accumulate instead of falling away. Psoriasis is the condition the brand addresses most prominently. Its website puts the number of people with psoriasis in Germany at around two million, and describes the typical plaques as thickened, inflamed patches covered in silvery-white scales, most often found on the scalp, the outer sides of the knees and elbows, and the lower back. The skin in these areas is often very dry and can itch or feel tight. Because the solution does not interfere with metabolism, the maker describes it as especially well tolerated. It presents LOYON as suitable for pregnant women, babies and older patients, and says it can be used from the first month of life. The owner's stated standards for its patient products are simple application, optimal tolerability and fast action. These are printed on the LOYON homepage and effectively double as the brand's values. Beyond the products themselves, the LOYON website works as a patient guide. It carries explanatory sections on psoriasis, dry skin, atopic eczema, seborrhoeic eczema, dry scalp and infant scalp crusting. Advice pages cover everyday topics such as home remedies, diet, sport, relationships and sexuality, and the psychological and social side of living with a skin condition, alongside a glossary and a separate section for healthcare professionals. ## Products & innovation The LOYON solution is made from two ingredients: dicaprylyl carbonate, an oily emollient, and dimeticones, a family of silicone oils. The Pharmazeutische Zeitung, a German pharmacy journal, identifies the emollient by its trade name, Cetiol CC [8]. The company calls the pairing a patented combination, although it does not publish a patent number [2]. According to the brand, the mixture seeps under and between the skin cells and spreads evenly. This weakens the bonds that hold the scales together, so they can be rinsed off the skin's surface afterwards. Pohl-Boskamp, as quoted in the trade press, attributes this to the liquid's particular ability to creep and spread across the skin. The company says the solution lifts scales and crusts without causing the small bleeding points that often appear when scales are removed mechanically. The solution is applied directly to scaly areas, either with a pipette, which the brand recommends for small patches and for the scalp, or with a spray head. LOYON lists psoriasis, seborrhoeic eczema and two kinds of scaling on infants' scalps, which it distinguishes as Milchschorf and Kopfgneis, among the conditions it can be used for. According to the manufacturer, the product does not sting, is not sticky and has no smell, and it contains no preservatives, colourants or fragrances. Trade-press coverage adds some practical detail. The Pharmazeutische Zeitung notes that the device contains no pharmacologically active substances and that its allergy potential is correspondingly low. As described there, it is applied once a day for about a week, after which no further improvement is to be expected [8]. LOYON Care, the second product, is presented as daily basic care to accompany the solution. It is a light, fat-free fluid that absorbs quickly, which the brand says makes it comfortable on hairy areas of the body, including an irritated scalp. Its key ingredient is dexpanthenol, which the company says soothes irritated skin, relieves itching and supports the skin's natural regeneration. LOYON Care is described as dermatologically tested and moisturising, with protection lasting up to 16 hours; the brand cites no study for that figure [4]. Like the main solution, it is free from preservatives, colourants and fragrances. ## Science & innovation In 2015 the Pharmazeutische Zeitung reported on a randomised comparison study of LOYON, presented at the annual meeting of the Gesellschaft für Dermopharmazie (Society for Dermopharmacy) [8]. The study included 90 patients with chronic scalp psoriasis and tested LOYON against 10 percent salicylic acid, which the journal called the gold standard for scale removal. On the primary endpoint, an improvement in scaling, the two preparations proved equivalent. LOYON, however, worked noticeably faster. After three days of treatment, the Psoriasis Scalp Severity Index, a combined score of scaling, redness and skin thickening, had fallen by 25 percent under LOYON, against 14 percent under salicylic acid [8]. The journal also reported that LOYON went twice as far in use as the comparison product. The report does not name the study's sponsor or a publication in a scientific journal. The LOYON website itself cites no study in support of its claims. ## Current status LOYON is an active brand. Its product pages were updated in May 2026, and Pohl-Boskamp continues to list it in its brand portfolio [2]. The products are sold through pharmacies; rather than running its own shop, the brand website directs buyers to online pharmacies [1]. ## Timeline {#belagg-timeline} | Year | Event | Source | |---|---|---| | 2014 | LOYON reaches the German market as a new keratolytic medical device (available since July 2014, per DAZ 32/2014 of 07.08.2014) | https://www.deutsche-apotheker-zeitung.de/daz-az/2014/daz-32-2014/loyon-r-loest-schonend-schuppen-und-krusten | | 2015 | Pharmazeutische Zeitung (25.03.2015) reports a randomised comparison study, presented at the Gesellschaft für Dermopharmazie annual meeting, in 90 patients with chronic scalp psoriasis. LOYON matched 10% salicylic acid on the primary endpoint and acted faster. | https://www.pharmazeutische-zeitung.de/ausgabe-132015/neuartiges-keratolytikum-versus-salicylsaeure/ | ## Signature products {#belagg-products} - **LOYON® (keratolytic solution for scaly skin conditions; pipette or spray head)** — LOYON® löst Hautschuppen und ist somit ein Keratolytikum. — https://www.loyon-schuppen.de/das-produkt - **LOYON® Care (fat-free fluid for dry, scaly, itchy skin)** — LOYON® Care ist ideal für die tägliche Pflege beanspruchter Haut. — https://www.loyon-schuppen.de/das-produkt/loyon-care ## Key ingredients {#belagg-ingredients} Dicaprylyl Carbonat · Dimeticone Source: https://www.loyon-schuppen.de/das-produkt ## Proprietary technologies & patents {#belagg-tech} - Patented combination of Dicaprylyl Carbonat and Dimeticone (patent number not stated) — https://www.loyon-schuppen.de/das-produkt ## Mentioned in {#belagg-press} - **Ärzte Zeitung** (2014) — Article 'Neues Keratolytikum für Psoriasis-Patienten' (published 2014-04-28 per page meta; body behind a login wall). — https://www.aerztezeitung.de/Medizin/Neues-Keratolytikum-fuer-Psoriasis-Patienten-241033.html - **Deutsche Apotheker Zeitung (DAZ 32/2014)** (2014) — Launch report 'Loyon® löst schonend Schuppen und Krusten' (07.08.2014). Only the teaser is public; it notes a comparison study against salicylic acid. — https://www.deutsche-apotheker-zeitung.de/daz-az/2014/daz-32-2014/loyon-r-loest-schonend-schuppen-und-krusten - **Pharmazeutische Zeitung (Ausgabe 13/2015)** (2015) — Study report 'Kopfhaut-Psoriasis: Neuartiges Keratolytikum versus Salicylsäure' (25.03.2015) — https://www.pharmazeutische-zeitung.de/ausgabe-132015/neuartiges-keratolytikum-versus-salicylsaeure/ ## Sources 1. (T1) https://www.loyon-schuppen.de/ 2. (T2) https://www.loyon-schuppen.de/das-produkt 4. (T2) https://www.loyon-schuppen.de/das-produkt/loyon-care 5. (T2) https://www.loyon-schuppen.de/impressum 7. (T2) https://www.pohl-boskamp.de/marken 8. (T4) https://www.pharmazeutische-zeitung.de/ausgabe-132015/neuartiges-keratolytikum-versus-salicylsaeure/ --- Glowpedia · · Published 2026-09-30 Please cite with a link to the article URL.